US FDA warns against $30 DIY alternative to Mylan's EpiPen
The US FDA has warned people not to use a $30 DIY epinephrine delivery device developed after Mylan increased the price of the Epipen.
Archives for September 21, 2016
Urine derived clot busters do not pose Zika risk says EMA
Clot busting drugs derived from human urine are no more likely to be contaminated with Zika virus than other medicines according to research by the EMA.
The final rule: trial data to be made public in a 'change of business as usual'
The Obama administration recently finalized new rules that require researchers to make trial data public as the industry grapples with evolving data standards and looks to uphold its pledge to clinical trial participants.
Crown Bio launches new feature for XenoBase in vitro models
Crown Bioscience has published an updated version of its XenoBase, an online database collating cell line and cell line derived xenograft model data.
Colorcon and Dow extend controlled release alliance
Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.
IDT Biologika: trends and demand in first year of US-based contract manufacturing operations
In its first year of operations, IDT Biologika’s contract manufacturing facility in Rockville, Maryland has experienced rapid growth, which it expects to continue as construction carries on.
Sartorius pledges to cut development times with upstream suite
Sartorius Stedim Biotech claims it has a platform that can help biopharma companies carve months off the development time for new products.